Low incidence of HCV reinfection: Exposure, testing frequency, or protective immunity?
Gregory J. Dore, Joanne Micallef – 26 April 2007
Venous outflow reconstruction with surgically reopened obliterated umbilical vein in domino liver transplantation
Hynek Mergental, Annette S.H. Gouw, Maarten J.H. Slooff, Koert P. de Jong – 24 April 2007
Hepatectomy vs. liver transplantation: A combination rather than an opposition
Jacques Belghiti, François Durand – 24 April 2007
PELD allocation and acute liver/graft failure
Rakesh Sindhi, Kyle Soltys, Geoffrey Bond, Amadeo Marcos, George Mazariegos – 24 April 2007
Stereological evaluation of liver volume in living donor liver transplantation using MDCT via the cavalieri method
Cihan Duran, Bulent Aydinli, Yaman Tokat, Yildiray Yuzer, Mecit Kantarci, Metin Akgun, Kamil Yalcin Polat, Bünyami Unal, Refik Killi, S. Selcuk Atamanalp – 24 April 2007 – In living donor liver transplantation (LDLT), obtaining the precise volume of the graft is very important to decrease volume‐related postoperative complications, especially in cases with suspected small‐for size grafts.
Liver transplantation for status 1: The consequences of good intentions
Sue V. McDiarmid, Nathan P. Goodrich, Ann M. Harper, Robert M. Merion – 24 April 2007 – Status 1 is the listing category reserved for patients awaiting liver transplantation who are at risk of imminent death. This high allocation priority was intended to benefit patients with acute liver failure and children with severe chronic liver failure. However, the status 1 criteria were not well defined.
Optical coherence tomography: Expanding use in the bile duct
James D. Perkins – 24 April 2007
MMF to EC‐MPS conversion: What makes the difference?
Hartmut Schmidt, Jens Brockmann – 24 April 2007
Recurrent hepatitis C: Worse outcomes established, interventions still inadequate
Marina Berenguer – 24 April 2007
Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation
Yesim Erim, Michael Böttcher, Uta Dahmen, Olof Beck, Christoph E. Broelsch, Anders Helander – 24 April 2007 – This study compared measurement of urinary ethyl glucuronide (EtG), a conjugated minor ethanol metabolite with a longer detection window than ethanol itself, with breath alcohol testing and self‐report as ways to disclose recent drinking by 18 liver transplant candidates with an alcoholic liver disease diagnosis that underwent an addiction group therapy program.